Related Experiment Video
Updated: Feb 13, 2026

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
Published on: June 18, 2013
A Reproducible Workflow for Macrophage Membrane Isolation and Nanocore Selection Toward Bioinspired Nanoparticles
Diana Peixoto1,2,3,4, Patricia Diaz-Rodriguez1, Francisco Veiga2,3
1Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Faculty of Pharmacy, iMATUS and Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago, Spain.
Researchers developed a reproducible method for creating macrophage membrane-coated nanoparticles (M2M-NPs) to target difficult "cold" tumors. This biomimetic nanoparticle strategy shows promise for improved cancer therapy and enhanced immune evasion.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- Macrophage membrane-coated nanoparticles (M2M-NPs) are promising for treating
- cold
- tumors resistant to conventional therapies.
- Current methods for membrane isolation and NP coating lack reproducibility, hindering clinical translation.
Purpose of the Study:
- To establish a reproducible workflow for isolating M2 macrophage plasma membranes.
- To develop and characterize a reliable method for preparing M2M-NPs.
- To evaluate the efficacy of M2M-NPs loaded with paclitaxel against specific cancer types.
Main Methods:
- Optimized workflow combining hypotonic lysis, Dounce homogenization, and differential centrifugation for membrane isolation.
- Development and characterization of membrane-derived nanovesicles (M2M-NVs) using fluorescent lipids and cholesterol.
- Systematic evaluation of different nanocores (TPGS, VD3, PLGA) for M2M coating efficiency, with PLGA NPs yielding optimal results.
Main Results:
- Consistent M2M fractions with reproducible protein, lipid, and DNA profiles were obtained.
- PLGA/M2M-NPs demonstrated high colloidal stability, hemocompatibility, and immune evasion.
- Paclitaxel-loaded PLGA/M2M-NPs exhibited selective cytotoxicity against triple-negative breast cancer, pancreatic, and glioblastoma cells.
Conclusions:
- A reproducible workflow for engineering macrophage membrane-based biomimetic NPs was established.
- The developed M2M-NPs show enhanced therapeutic potential for immunologically
- cold
- tumors.
- This work advances the translational potential of biomimetic nanoparticles in cancer therapy.
Related Concept Videos
Responses to Heat and Cold Stress
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cold Weather Concreting
To counteract the negative impacts of cold weather, ensuring...
Antibiotic Selection
What is Natural Selection?
Masonry in Cold and Hot Weather Conditions
Other key practices include keeping masonry units...

